Gimoti Shortage Update: What Patients Need to Know in 2026

If you've searched online for a "Gimoti shortage," you've probably found conflicting information. Let's clear the record: as of 2026, Gimoti (metoclopramide nasal spray) is not listed on the FDA's drug shortage database. However, that doesn't mean every patient can easily access it. The barriers are real — they're just different from a manufacturing shortage.

Is There an Official FDA Shortage of Gimoti in 2026?

No. The FDA maintains a public Drug Shortage Database, and as of 2026, Gimoti does not appear on that list. The FDA defines a drug shortage as a period when the supply of a drug is inadequate to meet the demand. Gimoti is available — it's just only dispensed through one specialty pharmacy (ASPN Pharmacies), which creates access friction that can feel like a shortage.

Why Patients Feel Like There Is a Shortage

Several factors make patients believe Gimoti is hard to find or in short supply:

Not at regular pharmacies. Gimoti is exclusively dispensed through ASPN Pharmacies. When patients call CVS, Walgreens, or their local drugstore, they're told it's not available — which reads as a "shortage" when it's actually a distribution model.

Prior authorization delays. Most insurance plans require PA before covering Gimoti. This 7–30 business day process creates a waiting period that feels like supply unavailability.

Prescription routing errors. If a doctor accidentally sends the Rx to a retail pharmacy, patients can wait weeks before realizing the prescription never reached ASPN.

Limited brand awareness. Gimoti was FDA-approved in 2020. Some prescribers and many pharmacists remain unfamiliar with its specialty-only distribution model.

Gimoti's History: From Approval to Market Access

Gimoti's path to patients was long. Evoke Pharma first filed for FDA approval of metoclopramide nasal spray years before eventual approval. The original NDA submission faced a Complete Response Letter from the FDA in 2019 before a successful resubmission. The FDA approved Gimoti in 2020. The active ingredient, metoclopramide, has been used in the US since 1979 in oral and injectable forms — Gimoti brings a new nasal delivery route.

Because no generic Gimoti is available (as of 2026), and because the drug is only sold through one specialty pharmacy network, supply is controlled but access can be delayed by insurance and logistics — not by manufacturing problems.

Is the Oral Metoclopramide (Generic) in Shortage?

Oral metoclopramide (generic Reglan) has periodically appeared on shortage lists, as injectable metoclopramide has in hospital settings. However, the tablet form — which is the alternative most patients would use — is widely available at retail pharmacies for approximately $4–$20 per month with discount programs. If you need to bridge to a cheaper alternative while awaiting Gimoti approval, oral metoclopramide is typically accessible.

What the 2025 AGA Guidelines Say About Gastroparesis Treatment

In 2025, the American Gastroenterological Association (AGA) published updated clinical practice guidelines on gastroparesis management. The guidelines issued conditional recommendations in favor of using metoclopramide and erythromycin for gastroparesis symptoms. Metoclopramide — in all its forms, including Gimoti — remains one of only two drugs conditionally recommended for gastroparesis treatment.

Steps to Take If You Can't Get Gimoti Right Now

Verify your prescription was sent to ASPN Pharmacies — call 1-844-244-6684.

If PA is pending: ask ASPN for an update. PA determinations take about 7 business days.

Consider the $20 cash option through ASPN if you need treatment now.

Talk to your doctor about a bridge prescription for oral metoclopramide or erythromycin while awaiting Gimoti.

If PA was denied, ask ASPN about the appeals process (Level of Medical Necessity appeal — approximately 30 days).

Getting Help Finding Your Medications

Navigating specialty medication access can feel overwhelming — especially when you're managing a chronic condition like diabetic gastroparesis. medfinder helps patients find which pharmacies can fill their prescriptions by contacting pharmacies on their behalf. Whether it's Gimoti, oral metoclopramide, or another medication you need, medfinder does the calling so you don't have to.

See also: Alternatives to Gimoti If You Can't Fill Your Prescription for details on bridging options.